195 related articles for article (PubMed ID: 30900217)
1. The Utility of Soluble CD14 Subtype in Early Diagnosis of Culture-Proven Early-Onset Neonatal Sepsis and Prediction of Outcome.
Gad GI; Shinkar DM; Kamel El-Din MM; Nagi HM
Am J Perinatol; 2020 Apr; 37(5):497-502. PubMed ID: 30900217
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.
van Maldeghem I; Nusman CM; Visser DH
BMC Immunol; 2019 Jun; 20(1):17. PubMed ID: 31159729
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review.
Maddaloni C; De Rose DU; Santisi A; Martini L; Caoci S; Bersani I; Ronchetti MP; Auriti C
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830040
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.
Ozdemir AA; Elgormus Y
Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177
[No Abstract] [Full Text] [Related]
6. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis.
Bellos I; Fitrou G; Pergialiotis V; Thomakos N; Perrea DN; Daskalakis G
Eur J Pediatr; 2018 May; 177(5):625-632. PubMed ID: 29476345
[TBL] [Abstract][Full Text] [Related]
7. Presepsin and fetuin-A dyad for the diagnosis of proven sepsis in preterm neonates.
Değirmencioğlu H; Ozer Bekmez B; Derme T; Öncel MY; Canpolat FE; Tayman C
BMC Infect Dis; 2019 Aug; 19(1):695. PubMed ID: 31387523
[TBL] [Abstract][Full Text] [Related]
8. Cord blood presepsin as a predictor of early-onset neonatal sepsis in term and preterm newborns.
Priolo F; Maggio L; Fattore S; Tedesco M; De Rose DU; Perri A; Prontera G; Chioma R; Sbordone A; Patti ML; Vento G
Ital J Pediatr; 2023 Mar; 49(1):35. PubMed ID: 36945009
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.
Yaegashi Y; Shirakawa K; Sato N; Suzuki Y; Kojika M; Imai S; Takahashi G; Miyata M; Furusako S; Endo S
J Infect Chemother; 2005 Oct; 11(5):234-8. PubMed ID: 16258819
[TBL] [Abstract][Full Text] [Related]
10. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
11. Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis.
Iskandar A; Arthamin MZ; Indriana K; Anshory M; Hur M; Di Somma S;
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3903-3908. PubMed ID: 29742943
[No Abstract] [Full Text] [Related]
12. Presepsin as a predictor of positive blood culture in suspected neonatal sepsis.
Miyosawa Y; Akazawa Y; Kamiya M; Nakamura C; Takeuchi Y; Kusakari M; Nakamura T
Pediatr Int; 2018 Feb; 60(2):157-161. PubMed ID: 29205640
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
14. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis.
Kumar N; Dayal R; Singh P; Pathak S; Pooniya V; Goyal A; Kamal R; Mohanty KK
Indian J Pediatr; 2019 Feb; 86(2):177-179. PubMed ID: 29577181
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
16. Serum level of soluble CD14 subtype predicts long-term prognosis in sepsis patients with cardiac dysfunction.
Liu J; Dai M; Yang H; Song L; Chen K; Wang Y; Hua M
Ann Palliat Med; 2020 Jul; 9(4):2054-2061. PubMed ID: 32692213
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis.
Zhou W; Rao H; Ding Q; Lou X; Shen J; Ye B; Xiang C
Lab Med; 2020 Nov; 51(6):614-619. PubMed ID: 32382753
[TBL] [Abstract][Full Text] [Related]
19. Serum Biomarkers for the Early Detection of the Early-Onset Neonatal Sepsis: A Single-Center Prospective Study.
Ahmed AM; Mohammed AT; Bastawy S; Attalla HA; Yousef AA; Abdelrazek MS; Fransawy Alkomos M; Ghareeb A
Adv Neonatal Care; 2019 Oct; 19(5):E26-E32. PubMed ID: 31651475
[TBL] [Abstract][Full Text] [Related]
20. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
Pugni L; Pietrasanta C; Milani S; Vener C; Ronchi A; Falbo M; Arghittu M; Mosca F
PLoS One; 2015; 10(12):e0146020. PubMed ID: 26720209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
